Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

TELMISARTAN; HYDROCHLOROTHIAZIDE

TELMISARTAN; HYDROCHLOROTHIAZIDE

Standard Dose
40MG; 12.5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: None (Tentative Approval)
Summary

Approval overview TELMISARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091084 (ANDA).

Marketing status: None (Tentative Approval) Active ingredient TELMISARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 40MG; 12.5MG Sponsor WATSON LABS FLORIDA Submission history Latest submission status date: 2011-09-15 00:00:00.

Structured Monograph

Clinical summary

Approval overview TELMISARTAN; HYDROCHLOROTHIAZIDE is listed in Drugs@FDA under application 091084 (ANDA). Marketing status: None (Tentative Approval) Active ingredient TELMISARTAN; HYDROCHLOROTHIAZIDE Form and strength TABLET; ORAL - 40MG; 12.5MG Sponsor WATSON LABS FLORIDA Submission history Latest submission status date: 2011-09-15 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: None (Tentative Approval)

Interaction Notes

  • No interaction notes stored yet.